Terms ending in 2038
Every in-force patent on Adimab, LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,312,761 | Anti-Respiratory Syncytial Virus Antibodies, and Methods of Their Generation and Use In force · High confidence | Gates Medical Research Institute | In force | High confidence | |
| US 11,661,460 | Anti-Coagulation Factor XI Antibodies In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,676,536 | Anti-Coagulation Factor XI Antibodies In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,836,810 | Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections In force · High confidence | Albert Einstein College of Medicine | In force | High confidence | |
| US 11,512,142 | Anti-Coagulation Factor XI Antibodies In force · Medium confidence | Merck Sharp & Dohme LLC | In force | Medium confidence | |
| US 11,479,615 | Anti-Coagulation Factor XI Antibodies In force · Medium confidence | Merck Sharp & Dohme LLC | In force | Medium confidence | |
| US 11,485,794 | Anti-Coagulation Factor XI Antibodies In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,242,378 | Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections In force · High confidence | Albert Einstein College of Medicine | In force | High confidence | |
| US 11,242,379 | Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections In force · High confidence | Albert Einstein College of Medicine | In force | High confidence | |
| US 11,407,816 | Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections In force · High confidence | Albert Einstein College of Medicine | In force | High confidence | |
| 17 more term ends in 2038 · Pro | |||||
10 of 27 patents shown. Soonest term end first, then patent number.
Pro members see all 27.
3 of these are in force and held by Adimab, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.